标准化过渡方案联合照护协调员优化慢阻肺急性期患者结局:一项随机临床试验
本研究在加拿大阿尔伯塔省五家医院实施慢阻肺急性加重过渡方案,并将接受方案的患者随机分配至照护协调员组或常规照护组,同时与未接受方案的常规照护患者比较。结果显示过渡方案降低7天和30天再入院风险,但增加住院时长和30天急诊再访风险,照护协调员未改善结局。
要点
- 过渡方案使7天再入院风险相对降低83%,30天再入院风险相对降低26%。
- 过渡方案与住院时长相对增加7.3%及30天急诊再访风险相对增加76%相关。
- 照护协调员对再入院或急诊再访均无影响。
核心结论
- 慢阻肺急性加重过渡方案降低7天和30天再入院率,但增加住院时长和30天急诊再访风险。
- 照护协调员未改善再入院或急诊再访结局。
研究设计与样本
- 暴露于过渡方案的患者随机分配照护协调员,协调员在出院后≤72小时内联系患者。
- 主要结局为7天、30天和90天再入院、中位住院时长及30天急诊再访。
主要发现
- 过渡方案组7天再入院相对风险降低83%(RR,0.17;95%CI,0.07-0.35)。
- 过渡方案组30天再入院相对风险降低26%(RR,0.74;95%CI,0.60-0.91)。
- 90天再入院无变化(RR,1.05;95%CI,0.93-1.18)。
- 过渡方案与住院时长相对增加7.3%相关(RR,1.07;95%CI,1.0-1.15)。
- 过渡方案与30天急诊再访风险相对增加76%相关(RR,1.76;95%CI,1.53-2.02)。
临床怎么用
- 可考虑对慢阻肺急性加重出院患者实施标准化过渡方案以降低短期再入院。
- 需关注过渡方案可能延长住院时长并增加30天急诊再访的风险。
- 照护协调员在此方案中未显示额外获益,资源分配需权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute exacerbations of COPD (AECOPD) are associated with high morbidity and mortality and frequent readmissions. RESEARCH QUESTION: What is the effectiveness of a COPD transition bundle, with and without a care coordinator, on rehospitalizations and ED revisits? STUDY DESIGN AND METHODS: Two patient cohorts were selected: (1) the group exposed to the transition bundle and (2) the group not exposed to the transition bundle (usual care group). Patients exposed subsequently were randomized to a care coordinator. An AECOPD transition bundle was implemented in the hospital; patients randomized to the care coordinator were contacted ≤ 72 h after discharge. Six hundred four patients (320 to the care coordinator and 284 to routine care) who met eligibility criteria from five hospitals across three cities in Alberta, Canada, were exposed to the transition bundle, whereas 3,106 patients discharged from the same hospitals received the usual care. Primary outcomes were 7-day, 30-day, and 90-day readmissions, median length of stay (LOS), and 30-day ED revisits. RESULTS: The transition bundle cohort were 83% (relative risk [RR], 0.17; 95% CI, 0.07-0.35) less likely to be readmitted within 7 days and 26% (RR, 0.74; 95% CI, 0.60-0.91) less likely to be readmitted within 30 days of discharge. Ninety-day readmissions were unchanged (RR, 1.05; 95% CI, 0.93-1.18). The transition bundle was associated with a 7.3% (RR, 1.07; 95% CI, 1.0-1.15) relative increase in LOS and a 76% (RR, 1.76; 95% CI, 1.53-2.02) greater risk of a 30-day ED revisit. The care coordinator did not influence readmission or ED revisits. INTERPRETATION: The COPD transition bundle reduced 7- and 30-day hospital readmissions while increasing LOS and ED revisits. The care coordinator did not improve outcomes. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT03358771; URL: www. CLINICALTRIALS: gov.
引用
- Atwood CE, Bhutani M, Ospina MB, et al. Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator: A Randomized Clinical Trial. Chest. 2022. PMID: 35405112. doi:10.1016/j.chest.2022.03.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。